Fractyl Health Inc (GUTS) Stock Price, Quote & News

Company Profile

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. It develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. The company also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-t...

Industry: Biotechnology

Sector: Healthcare

Phone: 781 902 8800

Website: fractyl.com

Address:

3 Van de Graaff Drive, Suite 200, Burlington, United States

StockMan3517 Jun. 26 at 9:20 PM

$GUTS stop pushing false narratives

0 · Reply

Rick2058 Jun. 26 at 8:59 PM

$GUTS Took profits from momentum trade of AMS and added to position today.

0 · Reply

summerof08 Jun. 26 at 8:21 PM

$SLS has anyone checked in on $GUTS ?

0 · Reply

Ked1977 Jun. 26 at 6:50 PM

$GUTS what’s the deal with this damn stock today?

1 · Reply

Morgott438734 Jun. 26 at 2:10 PM

$GUTS R/S play seeking entry around $0.15 respectively

0 · Reply

StockMan3517 Jun. 26 at 12:07 PM

$GUTS GUYS, RS won’t happen until after we see the data in August. Do not plan your buying around the RS compliance deadline. The catalyst is a month or so before then. DYOR NFA

1 · Reply

ISimplyHaveNoIdea Jun. 26 at 4:23 AM

$GUTS reaching out to @BioRich for some advice… How long after the RS you told me about coming up in September do you think is a good entry point?

0 · Reply

The_Birdie_Gambit Jun. 26 at 4:07 AM

$GUTS 10 consecutive days at $1.00?

0 · Reply

StockMan3517 Jun. 26 at 1:04 AM

$GUTS Yall, feel free to pump this to $1 if you want but it really isn’t necessary if you plan on holding this through the data ready out this summer. Compliance deadline is September so: Data is good: stock will be much higher than $1, problem solved before September, even if the price fell to $0.10 tomorrow. Data is bad: stock tanks as we all sell and the RS doesn’t even matter to us because no one has any shares left. See you at $8

0 · Reply